PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Catechol O-Methyltransferase 2,877 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.64
Glucocorticoid Receptor 10,306 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Epidermal Growth Factor Receptor 24,772 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Calmodulin 25,240 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
CD4 112,219 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Adult Respiratory Distress Syndrome 4,034 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.62
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
Hyperbilirubinemia 5,757 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.61
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Sedimentation Rate 11,455 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.60
Bronchitis 18,336 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.60
Bladder Cancer 21,509 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.59
Glomerulonephritis 23,459 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.60
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
Chronic Obstructive Pulmonary Disease 27,780 Disease Target A1AT 329 22 0.01 -0.97 0.07 0.64
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Hepatitis B 57,815 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.58
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
Pneumonia 81,521 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.55
Lung Cancer 91,416 Disease Target A1AT 329 7 0.00 -0.99 0.02 0.57
Hemorrhage 100,979 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.54
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Shock 134,031 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.53
Obesity 138,233 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.55
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Diabetes 332,602 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.51
Carcinoma 433,099 Disease Target A1AT 329 22 0.00 -0.97 0.07 0.56
Infection 766,637 Disease Target A1AT 329 16 0.00 -0.98 0.05 0.54
Cancer 1,053,491 Disease Target A1AT 329 34 0.00 -0.95 0.10 0.55
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
CCL18 256 Target Target A1AT 329 2 0.01 -0.99 0.01 0.72
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
Cathepsin G 1,613 Target Target A1AT 329 2 0.00 -1.00 0.01 0.65
Ns3 3,189 Target Target A1AT 329 1 0.00 -1.00 0.00 0.61
C5a 4,164 Target Target A1AT 329 1 0.00 -1.00 0.00 0.60
CD68 6,424 Target Target A1AT 329 2 0.00 -1.00 0.01 0.61